Flunixin Meglumine

Producers shown on SFDA

(Record date:22/10/2021）

Producers shown on EP

(Quoted from EP website；record date:22/10/2021）

Producer:Hubei Zhongmu Anda Pharmaceutical Co., Ltd. is a large high-tech enterprise integrating scientific research, development, production and sales of chemical synthetic veterinary drug raw materials and preparations and feed additives. The company obtained the enterprise GMP certificate in 2005, with an annual production of more than 5000 tons of various veterinary drug raw materials and preparations.

Staff size:200-299 people

Registered capital:RMB 61.25 million

Producer:Shandong Runhua Veterinary Drug Co., Ltd., established in 1998, now covers an area of 35273 ㎡ and a construction area of 15000 ㎡. Existing veterinary APIs: dihydropyridine, calcium carbapelin, oxytetracycline hydrochloride, tilmicosin, tilmicosin phosphate, sodium sulfamethoxam, flunixin meglumine hydrochloride, cefotiofur hydrochloride, cefotiofur sodium (sterile), cefquinoxime sulfate (sterile); Veterinary preparations: ten production lines: powder, powder, premix, oral solution, non chlorine preparations, liquid disinfectant / insecticide, solid disinfectant / insecticide, traditional Chinese medicine extraction, additive premix feed and feed additive.

Staff size:About 50 people

Registered capital:RMB 30 million

Producer:Qilu Shenghua Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Qilu Pharmaceutical Group, is mainly engaged in the development, production and sales of veterinary chemical synthetic APIs, biological pesticides and veterinary preparations.

The company has passed FDA and EU GMP certification, and all veterinary chemical raw materials and preparations have passed GMP certification in China. With excellent product quality and strict and standardized management, the leading products such as cefotaxime sodium, cefquinome sulfate, abamectin and benzoate have the first domestic market share.

Registered capital:RMB 50 million

Producer:Shandong Jiulong Hengxin Pharmaceutical Co., Ltd. was established in 2005, covering an area of more than 30 mu. It mainly produces veterinary APIs and intermediates. The company invested 5 million to establish a GMP fine drying car room, which successfully passed the GMP acceptance and obtained the production document number of corresponding products.

Staff size:About 50 people

Registered capital:RMB 3 million

Producer:Henan Haitian Biotechnology Co., Ltd. was established in 2012，is a manufacturer of animal medicine and health products integrating R & D, production, sales and service. The company has passed the GMP certification of veterinary drugs by the Ministry of agriculture, covering an area of 30000 square meters, has a standard workshop of 5000 square meters that can meet the production process requirements, storage facilities of 2000 square meters, and has a number of production lines, including powder powder, premix, powder injection, water injection, disinfectant, oral liquid, insecticide, etc. The annual production of powder injection is 100 million. At present, it is one of the largest production lines in Asia.

Staff size:About 50 people
Registered capital:RMB 5 million

Producer:Zhejiang Hisoar Pharmaceutical Co.,Ltd. located in Taizhou, Zhejiang Province, is a listed company controlled by Donggang group, which mainly produces characteristic APIs, preparations, fine chemicals, dyes and dye intermediates.

The company's main products are antibiotics, cardiovascular, hypoglycemic and other APIs, fine chemicals, preparations, dyes and intermediates. More than 70% of pharmaceutical products are exported, and the output of clindamycin series is firmly in the leading position in the world. The company attaches great importance to the construction of EHS and GMP system. Dozens of products have registered with the US FDA, obtained the EU CEP (COS) certificate, passed the Japanese GMP certification and domestic GMP certification. Dye products are exported to more than 30 countries and regions such as Europe, America and Asia. The leading product reactive brilliant blue KN-R accounts for more than 60% of the global market share. It is in a leading position in the industry in terms of industrial scale, technical quality and product application“ "Dye eight brand" reactive dyes are rated as China's famous brand products and national excellent torch plan projects. They are one of the three famous brand dyes in China.

Staff size:About 500 people

Registered capital:RMB 1 billion 618 million 715 thousand and 253 

Producer:Longyan Taimai Sanluck Pharmaceutical Co., Ltd.was established in 2009. The GMP acceptance scope is: Powder / powder / premix, non sterile API (flunixin meglumine), non chlorine disinfectant (solid) and non chlorine disinfectant (liquid).

Staff size:About 50 people
Registered capital:RMB 3 million

Producer:Shandong Lukang Sherile Pharmaceutical Co., Ltd., established in 1993, is the veterinary drug sector of Lukang medicine. The company has passed ISO9001, ISO14001 and occupational safety and health management system certification at one time. All products have passed the national GMP certification, and some products have passed the FDA certification.

Staff size:1000-1999 people

Registered capital:RMB 255 million 880 thousand

Producer:Fujian Weijia Biopharm Co., Ltd., established in 2016, is a subsidiary of Fujian Weijia biomedical Co., Ltd. It has 100 ㎡ pilot plant and 500 ㎡ large-scale production workshop, and GMP certificates and production approvals for four veterinary drug varieties such as praziquantel and difloxacin hydrochloride.

Staff size:About 50 people
Registered capital:RMB 10 million

Producer:Shaoxing Minsheng Pharmaceutical Co., Ltd., established in 2002, is a subsidiary of Hangzhou Minsheng pharmaceutical Holding Group Co., Ltd.

The company produces more than 20 kinds of semi synthetic pharmaceutical raw materials such as alanyl glutamine, praziquantel, thiadiazine series, scopolamine series and vinblastine series. Among them, 9 products have passed FDA certification.

Staff size:500-599 people

Registered capital:RMB 88 million

Producer:Qilu Synva Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Qilu Pharmaceutical Group, is mainly engaged in the development, production and sales of veterinary chemical synthetic APIs, biological pesticides and veterinary preparations. The company has passed FDA and EU GMP certification, and all veterinary chemical APIs and preparations have passed GM certification in China.
Staff size:600-699 people

Registered capital:RMB 50 million

Producer:Hubei Longxiang Pharmaceutical Tech. Co., Ltd., founded in 2008, covers an area of 400 mu. It is the main supplier of API for the top 10 large preparation factories in China. The products are veterinary APIs, preparations and pharmaceutical intermediates. It is one of the top ten manufacturers of veterinary APIs in China and an enterprise meeting the GMP standard of veterinary drugs.

Staff size:300-399 people

Registered capital:RMB 122 million 589 thousand and 200

For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978